ArticleCureus2026
Recurrent Pericarditis With Cardiac Tamponade in a Patient With Systemic Lupus Erythematosus: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 29-year-old male with a history of systemic lupus erythematosus (SLE) with class IV/V lupus nephritis, recurrent pericardial effusions, hypertension, and type 2 diabetes mellitus presented for worsening chest tightness and shortness of breath. Echocardiography revealed a large, free-flowing pericardial effusion circumferential to the heart, up to 2.9 cm at its widest diameter, with mild atrial and right ventricular collapse. Due to concern for tamponade, interventional cardiology was consulted, and a pericardiocentesis was performed, yielding 820 mL of serosanguinous fluid, and a pericardial drain was kept in place. Given his history of SLE, immunosuppressive therapy was started with intravenous methylprednisolone pulse dosing 250 mg twice a day for three days, followed by an oral prednisone taper and mycophenolate mofetil 500 mg twice a day titrating up to 1500 mg twice a day, as well as increasing hydroxychloroquine to 400 mg daily from 200 mg daily, starting colchicine 0.6 mg daily, and continuing voclosporin 23.7 mg twice a day. However, his pericardial effusion persisted, ultimately requiring a pericardial window. Unfortunately, just a few weeks later, he returned again with recurrent pleuropericarditis in spite of aggressive medical and surgical management and ultimately elected to leave against medical advice. This case highlights the challenges in managing recurrent pericardial effusions in patients with SLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.